Prolonged versus Intermittent Infusion of b Lactams for the Treatment of Nosocomial Pneumonia: A Meta Analysis
Background The primary objective of this meta analysis is aimed at determining whether b lactams prolonged infusion in patients with nosocomial pneumonia (NP) results in higher cure rate and improved mortality compared to intermittent infusion. Materials and Methods Relevant studies were identified from searches of MEDLINE, EMBASE, and CENTRAL from inception to September 1st, 2015. All published articles which evaluated the outcome of extended/continuous infusion of antimicrobial therapy versus intermittent infusion therapy in the treatment of NP were reviewed. Results A total of ten studies were included in the analysis involving 1,051 cases of NP. Prolonged infusion of b lactams was associated with higher clinical cure rate (OR 2.45, 95% CI, 1.12, 5.37) compared to intermittent infusion. However, there was no significant difference in mortality (OR 0.85, 95% CI 0.63 1.15) between the two groups. Subgroup analysis for b lactam subclasses and for severity of illness showed comparable outcomes. Conclusion The limited data available suggest that reduced clinical failure rates when using prolonged infusions of b lactam antibiotics in critically ill patients with NP. More detailed studies are needed to determine the impact of such strategy on mortality in this patient population.
Infection chemotherapy